CIBC Private Wealth Group
VKTX icon

CIBC Private Wealth Group’s Viking Therapeutics VKTX Stock Holding History

CIBC Private Wealth Group’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$17.6K Buy
+500
New +$17.7K ﹤0.01% 2211
2025
Q3 		– Sell
-22
Closed -$583 – 3316
2025
Q2 		$583 Sell
22
-1,339
-98% -$35.2K ﹤0.01% 2818
2025
Q1 		$27.2K Buy
1,361
+10
+0.7% +$316 ﹤0.01% 1883
2024
Q4 		$54.9K Buy
1,351
+851
+170% +$48.5K ﹤0.01% 1654
2024
Q3 		$31.7K Sell
500
-7
-1% -$411 ﹤0.01% 1953
2024
Q2 		$25.9K Buy
+507
New +$33.2K ﹤0.01% 1939
2018
Q3 		– Sell
-2,000
Closed -$19K – 1707
2018
Q2 		$19K Buy
+2,000
New +$13.3K ﹤0.01% 1422

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return